Simon Craddock Lee1,2, Emily G Marks3, Joanne M Sanders3, Deborah J Wiebe4. 1. Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines, Boulevard, Dallas, 75390-9066, TX, USA. simoncraddock.lee@utsouthwestern.edu. 2. Harold C. Simmons Cancer Center, 2201 Inwood Road, Dallas, 75390-8590, TX, USA. simoncraddock.lee@utsouthwestern.edu. 3. Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines, Boulevard, Dallas, 75390-9066, TX, USA. 4. Program in Psychological Sciences, University of California-Merced, 5200 North Lake Road, Merced, 95343, CA, USA.
Abstract
PURPOSE: We explored patient-perceived role in "decision-making" related to active treatment and palliation among African Americans receiving lung cancer care through a county safety-net system. METHODS: Drawing from a cohort of over 100 African Americans treated in a safety-net hospital, we invited a subsample of 13 patient-caregiver dyads to participate in a series of dyadic, ethnographic interviews conducted at the patients' homes. Over 40 h of transcripts were analyzed in an iterative process resulting in reported themes. RESULTS: Findings from ethnographic interviews demonstrated that healthcare communication with physicians is difficult for patients. While caregivers and patients describe a deep engagement in lung cancer care, they expressed a concurrent lack of understanding of their prognosis and outcomes of treatment. Dyads did not discuss their lung cancer experience in terms of decision-making; rather, most articulated their role as following physician guidance. Distinct lack of understanding about disease course, severity, and prognosis may constrain patient perception of the need for informed decision-making over the course of care. CONCLUSIONS: Dyadic interviews detailing safety-net patient experiences of lung cancer care raise important questions about how clinicians, as well as researchers, conceptualize processes of informed decision-making in vulnerable populations. IMPLICATIONS FOR CANCER SURVIVORS: Safety-net patients may not perceive their role as involving informed decision-making and further may lack understanding of disease course and individual prognosis. Safety-net patient dyads expressed high involvement in care and a desire for clarity; clinicians should be prepared to clearly communicate disease stage and prognosis.
PURPOSE: We explored patient-perceived role in "decision-making" related to active treatment and palliation among African Americans receiving lung cancer care through a county safety-net system. METHODS: Drawing from a cohort of over 100 African Americans treated in a safety-net hospital, we invited a subsample of 13 patient-caregiver dyads to participate in a series of dyadic, ethnographic interviews conducted at the patients' homes. Over 40 h of transcripts were analyzed in an iterative process resulting in reported themes. RESULTS: Findings from ethnographic interviews demonstrated that healthcare communication with physicians is difficult for patients. While caregivers and patients describe a deep engagement in lung cancer care, they expressed a concurrent lack of understanding of their prognosis and outcomes of treatment. Dyads did not discuss their lung cancer experience in terms of decision-making; rather, most articulated their role as following physician guidance. Distinct lack of understanding about disease course, severity, and prognosis may constrain patient perception of the need for informed decision-making over the course of care. CONCLUSIONS: Dyadic interviews detailing safety-net patient experiences of lung cancer care raise important questions about how clinicians, as well as researchers, conceptualize processes of informed decision-making in vulnerable populations. IMPLICATIONS FOR CANCER SURVIVORS: Safety-net patients may not perceive their role as involving informed decision-making and further may lack understanding of disease course and individual prognosis. Safety-net patient dyads expressed high involvement in care and a desire for clarity; clinicians should be prepared to clearly communicate disease stage and prognosis.
Authors: John F P Bridges; Ateesha F Mohamed; Henrik W Finnern; Anette Woehl; A Brett Hauber Journal: Lung Cancer Date: 2012-02-25 Impact factor: 5.705
Authors: Angelique B Bouma; Kristina Tiedje; Sara Poplau; Deborah H Boehm; Nilay D Shah; Matthew J Commers; Mark Linzer; Victor M Montori Journal: J Am Board Fam Med Date: 2014 Mar-Apr Impact factor: 2.657
Authors: Rachel L Johnson; Somnath Saha; Jose J Arbelaez; Mary Catherine Beach; Lisa A Cooper Journal: J Gen Intern Med Date: 2004-02 Impact factor: 5.128
Authors: Erin L Mead; Ardith Z Doorenbos; Sara H Javid; Emily A Haozous; Lori Arviso Alvord; David R Flum; Arden M Morris Journal: Am J Public Health Date: 2013-10-17 Impact factor: 9.308
Authors: Jada G Hamilton; Sarah E Lillie; Dana L Alden; Laura Scherer; Megan Oser; Christine Rini; Miho Tanaka; John Baleix; Mikki Brewster; Simon Craddock Lee; Mary K Goldstein; Robert M Jacobson; Ronald E Myers; Brian J Zikmund-Fisher; Erika A Waters Journal: J Behav Med Date: 2016-08-26
Authors: Carlo L Acerini; David Segal; Sherwin Criseno; Kei Takasawa; Navid Nedjatian; Sebastian Röhrich; Mohamad Maghnie Journal: Front Endocrinol (Lausanne) Date: 2018-11-22 Impact factor: 5.555